MADISON, Wis., Oct. 25, 2021 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today shared data from modeling analyses that demonstrate Cologuard (mt-sDNA), with its included patient navigation ...
The Medicare Advantage Advanced Notice and Draft Call letter now includes Exact Sciences’ Cologuard. “The proposed inclusion of Cologuard in the Star Ratings program is an important step toward it ...
Hosted on MSN
Popular At-Home Colon Cancer Test Gets an Upgrade
The newest version of Cologuard, an at-home colon cancer screening test, results in fewer false positives that can lead to unnecessary follow-up procedures. Cologuard Plus also gives people more time ...
June 27--Cologuard, the colorectal cancer screening test by Madison-based Exact Sciences, got a boost this month when a prominent task force dropped its "alternative" designation for the test and ...
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, is teaming up with actor and horror icon Matthew Lillard to encourage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback